• Login
    View Item 
    •   Home
    • The Christie Research Publications Repository
    • All Christie Publications
    • View Item
    •   Home
    • The Christie Research Publications Repository
    • All Christie Publications
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Browse

    All of ChristieCommunitiesTitleAuthorsIssue DateSubmit DateSubjectsThis CollectionTitleAuthorsIssue DateSubmit DateSubjects

    My Account

    LoginRegister

    Local Links

    The Christie WebsiteChristie Library and Knowledge Service

    Statistics

    Display statistics

    Pharmacokinetics, safety and tolerability of olaparib and temozolomide for recurrent glioblastoma: results of the phase I OPARATIC trial

    • CSV
    • RefMan
    • EndNote
    • BibTex
    • RefWorks
    Thumbnail
    Name:
    noaa104.pdf
    Size:
    1.121Mb
    Format:
    PDF
    Description:
    From UNPAYWALL
    Download
    Authors
    Hanna, C
    Kurian, KM
    Williams, K
    Watts, C
    Jackson, A
    Carruthers, R
    Strathdee, K
    Cruickshank, G
    Dunn, L
    Erridge, S
    Godfrey, L
    Jefferies, S
    McBain, Catherine A
    Sleigh, R
    McCormick, A
    Pittman, M
    Halford, S
    Chalmers, AJ
    Show allShow less
    Affiliation
    Institute of Cancer Sciences, University of Glasgow, United Kingdom.
    Issue Date
    2020
    
    Metadata
    Show full item record
    Citation
    Hanna C, Kurian KM, Williams K, Watts C, Jackson A, Carruthers R, et al. Pharmacokinetics, safety and tolerability of olaparib and temozolomide for recurrent glioblastoma: results of the phase I OPARATIC trial. Neuro Oncol. 2020.
    Journal
    Neuro-Oncology
    URI
    http://hdl.handle.net/10541/622964
    DOI
    10.1093/neuonc/noaa104
    PubMed ID
    32347934
    Additional Links
    https://dx.doi.org/ 10.1093/neuonc/noaa104
    Type
    Article
    Language
    en
    ae974a485f413a2113503eed53cd6c53
    10.1093/neuonc/noaa104
    Scopus Count
    Collections
    All Christie Publications

    entitlement

    Related articles

    • Phase I/IIa study of concomitant radiotherapy with olaparib and temozolomide in unresectable or partially resectable glioblastoma: OLA-TMZ-RTE-01 trial protocol.
    • Authors: Lesueur P, Lequesne J, Grellard JM, Dugué A, Coquan E, Brachet PE, Geffrelot J, Kao W, Emery E, Berro DH, Castera L, Goardon N, Lacroix J, Lange M, Capel A, Leconte A, Andre B, Léger A, Lelaidier A, Clarisse B, Stefan D
    • Issue date: 2019 Mar 4
    • The Combination PARP Inhibitor Olaparib With Temozolomide in an Experimental Glioblastoma Model.
    • Authors: Hwang K, Lee JH, Kim SH, Go KO, Ji SY, Han JH, Kim CY
    • Issue date: 2021 Jul-Aug
    • Olaparib Is a Mitochondrial Complex I Inhibitor That Kills Temozolomide-Resistant Human Glioblastoma Cells.
    • Authors: Zampieri LX, Sboarina M, Cacace A, Grasso D, Thabault L, Hamelin L, Vazeille T, Dumon E, Rossignol R, Frédérick R, Sonveaux E, Lefranc F, Sonveaux P
    • Issue date: 2021 Nov 3
    • Olaparib and temozolomide in desmoplastic small round cell tumors: a promising combination in vitro and in vivo.
    • Authors: van Erp AEM, van Houdt L, Hillebrandt-Roeffen MHS, van Bree NFHN, Flucke UE, Mentzel T, Shipley J, Desar IME, Fleuren EDG, Versleijen-Jonkers YMH, van der Graaf WTA
    • Issue date: 2020 Jul
    • A phase I trial of veliparib (ABT-888) and temozolomide in children with recurrent CNS tumors: a pediatric brain tumor consortium report.
    • Authors: Su JM, Thompson P, Adesina A, Li XN, Kilburn L, Onar-Thomas A, Kocak M, Chyla B, McKeegan E, Warren KE, Goldman S, Pollack IF, Fouladi M, Chen A, Giranda V, Boyett J, Kun L, Blaney SM
    • Issue date: 2014 Dec
    DSpace software (copyright © 2002 - 2023)  DuraSpace
    Quick Guide | Contact Us
    Open Repository is a service operated by 
    Atmire NV
     

    Export search results

    The export option will allow you to export the current search results of the entered query to a file. Different formats are available for download. To export the items, click on the button corresponding with the preferred download format.

    By default, clicking on the export buttons will result in a download of the allowed maximum amount of items.

    To select a subset of the search results, click "Selective Export" button and make a selection of the items you want to export. The amount of items that can be exported at once is similarly restricted as the full export.

    After making a selection, click one of the export format buttons. The amount of items that will be exported is indicated in the bubble next to export format.